N-ACETYL CYSTEINE IN THE ADJUNCTIVE TREATMENT OF OBSESSIVE COMPUSLIVE DISORDER: A 16-week, Double-Blind, Randomised, Placebo-Controlled Study

我们提出的研究的目的是调查辅助n -乙酰半胱氨酸（NAC）的有效性和安全性，NAC是一种以氨基酸为基础的药物，用于治疗200名诊断为强迫症的成年人。这项研究是一项为期16周的双盲、随机、安慰剂对照试验。如果NAC在本研究中被发现是有效的，那么强迫症的治疗将受到强烈的影响，从而对减轻精神障碍患者的痛苦产生全球影响。

The aim of our proposed study, is investigate the efficacy and safety of adjunctive N-acetyl cysteine (NAC), an amino-acid based agent in the treatment of 200 adults with diagnosed OCD. The study proposed is a 16-week, doubled-blind, randomised, placebo-controlled trial. If NAC is found to be effective in this study, the treatment of OCD will be strongly influenced, resulting in global impact for the potential alleviation of suffering for those with the mental disorder.